Paul is Chief Medical Officer for Humedica, a next-generation clinical informatics company that provides novel business intelligence solutions to the health care and life science industry. At Humedica, he has responsibility for medical informatics, data analytics and consulting, and product development. Prior to this, he was the founder and original CEO of Phase Forward where he helped grow the organization over an 11 year period from a concept to a publicly traded company serving in various capacities as Chief Strategy Officer. He remains a member of the Board of Directors. Prior to founding Phase Forward, Paul served as Vice President of Clinical Affairs at Alpha-Beta Technology with responsibility for Phase I through III clinical development of a novel carbohydrate drug. Paul was previously the Director, Early Phase Services at PAREXEL International where he assisted pharmaceutical and biotechnology companies with the initial development of novel therapies.
Paul currently serves on the editorial boards of Applied Clinical Trials and the Drug Information Journal. He has held various leadership positions in the Drug Information Association, including Chairman of the Steering Committee of North America for the Drug Information Association, a member of their Board of Directors and a member of the Board of the DIA Foundation. He is also a member of the Dean’s Advisory Council, School of Science at Rensselaer Polytechnic Institute, the Massachusetts Life Sciences Leadership Council the Board of Overseers of the Museum of Science in Boston.
In 2002, Paul won the Ernst and Young Entrepreneur of the Year Award in New England and was appointed to the Ernst and Young Entrepreneur’s Hall of Fame. He was named the 2003 recipient of the Rensselaer Alumni Association Fellows Award.
Paul received his BS from Rensselaer Polytechnic Institute, and his MD and PhD from the University of Rochester School of Medicine and Dentistry, specializing in cellular immunology. He trained in internal medicine at the Beth Israel Hospital, and dermatology at Harvard Medical School/ Massachusetts General Hospital. He did a post-doctoral fellowship at the Dana Farber Cancer Institute in molecular biology, and began his career as a physician/investigator and Assistant Professor at the Massachusetts General Hospital and Harvard Medical School.
